SecBot SecBot
Institutional Cluster

ERAS

Erasca, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago
Institutional cluster: 16 buyers, 1 sellers (bullish)
Actionable Insight ▲ Bullish

The institutional cluster is a strong bullish signal, particularly given the dominance of active managers and the actuarial amplifier flag for the offering+cluster combo. However, the lack of insider buying and the 45-day 13F reporting lag warrant caution. Monitor for any insider open-market purchases or further pipeline catalysts (ERAS-0015 data) that could confirm the thesis.

DirectionBullish
Confidencehigh
Horizonweeks

ERAS-0015

◆ Mixed Named in this fund cluster
Impact
Phase
Phase 1
Time to market
~3-5 years, assuming registration-enabling trials initiate in 2027 and a potential approval by ~2029-2030
Next catalyst
None dated

What to watchERAS-0015 Phase 1 data is genuinely strong (57-62% response rates in difficult-to-treat tumors) but the stock carries heavy legal baggage, a securities class action and patent-infringement allegations from Revolution Medicines. The stock recovered from its April 48% crash to ~$18; watch for the August 10, 2026 lead-plaintiff deadline and any developments in the Revolution Medicines patent dispute, which could swing shares sharply. The registration-enabling trial initiations in H1 2027 are the next major de-risking catalyst.

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$17.86
T+0 close · Aug 13, 2026 · via day close
Latest settled
−19.32%
T+60 · $14.41
Vs SPY
−13.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $17.86entry
  2. T+1 · 3mo ago +2.91%α +3.11% · $18.38
  3. T+5 · 3mo ago −4.37%α −2.40% · $17.08
  4. T+20 · 2mo ago −11.09%α −9.34% · $15.88
  5. T+60 · 11d ago −19.32%α −13.84% · $14.41

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A strong institutional cluster formed in ERAS during 2026-Q2, with 16 buyers accumulating $104.2M net against just 1 seller trimming $4.5M. The buying is dominated by active asset managers, including three new positions from Capital World Investors ($12.9M), Assenagon ($14.9M), and Jennison Associates ($51.1M), the latter being the largest single new stake. This cluster follows a $550M follow-on offering 29 days ago, and the cross-filing actuarial verdict flags this combo (offering + institutional cluster) as a statistically significant amplifier.

Key Financial Metrics

Direction
accumulating
Buy Value
$116.2M
Sell Value
$13.8M
Net Flow
$104.2M

Institutional Positions

Net institutional flow: $104.2M

▲ Buyers (16)

InstitutionActionChangePosition ValueValue Δ
Jennison AssociatesNEW+0%$51.1M$51.1M
Assenagon Asset ManagementNEW+0%$14.9M$14.9M
Capital World InvestorsNEW+0%$12.9M$12.9M
CitigroupDOUBLED+1352.9%$13.1M$12.3M
Td Asset ManagementADD+67.7%$12.1M$5.7M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
JPMorganTRIM-45.8%$13.8M-$4.5M

Key Facts

  • 16 institutions accumulated $104.2M net in ERAS during 2026-Q2
  • Jennison Associates opened a new $51.1M position, the largest single buy
  • Capital World Investors and Assenagon each opened new positions of $12.9M and $14.9M respectively
  • Only 1 seller (JPMorgan) trimmed $4.5M, representing minimal sell-side pressure
  • Cluster follows a $550M follow-on offering 29 days ago; cross-filing actuarial verdict flags this combo as an amplifier
  • No insider open-market buying corroborates the institutional cluster

Financial Impact

16 institutional buyers accumulated $104.2M in net new positions, while 1 seller reduced holdings by $4.5M, resulting in a net inflow of approximately $99.7M

institutional ownershipfloatvaluation

Risk Factors

  • 13F data is 45+ days stale; the cluster may have already been unwound
  • No insider open-market buying to corroborate the institutional thesis
  • Recent $550M dilutive offering could cap near-term upside

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ERAS-2026-Q2

Track record

26 reports on ERAS

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +95.35% at T+60 after the Apr 27, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $15.21 settles Feb 12
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.31 settles Feb 12
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.35 settles Feb 12
  4. Nov 12, 20264d ago Press Release Neutral 4/10 Entry $15.66 settles Feb 11
  5. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $14.64 settles Feb 1
  6. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $13.39 settles Jan 13
  7. Aug 24, 202612w ago 8-K Bullish 5/10 Entry $17.60 settles Nov 17
  8. Aug 17, 202613w ago 144 Neutral 3/10 Entry $18.28 to $15.61 ▼ −14.61% −11.84% vs SPY
  9. Aug 13, 202613w ago Institutional Cluster Bullish 6/10 Viewing Entry $17.86 to $14.41 ▼ −19.32% −13.84% vs SPY
  10. Aug 12, 202613w ago 3 Neutral 2/10 Entry $17.86 to $14.41 ▼ −19.32% −13.84% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 9h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026